News

Prenetics to Participate in the 37th Annual ROTH Conference

CHARLOTTE, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company, announced…

10 months ago

Cellectar Biosciences to Present at the 37th Annual Roth Conference

FLORHAM PARK, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused…

10 months ago

Teladoc Health Expands Connected Care Partnerships

New digital health partners in specialty care, digestive health, fertility, and family building available for Teladoc Health care team referral…

10 months ago

genXtraits and Norfolk Healthy Produce to collaborate on breeding of nutritionally enhanced tomatoes

ALAMEDA ISLAND, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- genXtraits Inc. (genXtraits) and Norfolk Healthy Produce Inc. (NHP) today announced…

10 months ago

Glass House Brands to Host Fourth Quarter and Full Year 2024 Conference Call on March 25, 2025

LONG BEACH, Calif. and TORONTO, March 11, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company")…

10 months ago

X4 Pharmaceuticals to Report Fourth-Quarter and Full-Year 2024 Financial Results and Host a Conference Call and Webcast on March 25, 2025

BOSTON, March 11, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people…

10 months ago

Better Life Partners Expands into North Carolina with Whole-Person Care for Substance Use Disorders

WATERTOWN, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Better Life Partners is expanding its mission of compassionate, community-based care to…

10 months ago

Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors

Fred Craves, Ph.D. to retire from Madrigal’s Board of Directors in July 2025 CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE)…

10 months ago

Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate

- Topline data expected as early as mid-2025 - SOUTH SAN FRANCISCO, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Vaxart,…

10 months ago

Sagimet Biosciences Announces Clearance of IND for FASN Inhibitor TVB-3567, to be Developed for the Treatment of Acne

TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 SAN MATEO,…

10 months ago